相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HLA-independent T cell receptors for targeting tumors with low antigen density
Jorge Mansilla-Soto et al.
NATURE MEDICINE (2022)
CAR T cell killing requires the IFN gamma R pathway in solid but not liquid tumours
Rebecca C. Larson et al.
NATURE (2022)
Size-dependent activation of CAR-T cells
Qian Xiao et al.
SCIENCE IMMUNOLOGY (2022)
Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities
Xueyin Wang et al.
MOLECULAR IMMUNOLOGY (2021)
Quantitative contributions of TNF receptor superfamily members to CD8+ T-cell responses
John Nguyen et al.
MOLECULAR SYSTEMS BIOLOGY (2021)
T cell circuits that sense antigen density with an ultrasensitive threshold
Rogelio A. Hernandez-Lopez et al.
SCIENCE (2021)
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
Yue Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function
Alexander Salter et al.
SCIENCE SIGNALING (2021)
The discriminatory power of the T cell receptor
Johannes Pettmann et al.
ELIFE (2021)
Perfect adaptation of CD8+ T cell responses to constant antigen input over a wide range of affinities is overcome by costimulation
Nicola Trendel et al.
SCIENCE SIGNALING (2021)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Tuning the Antigen Density Requirement for CAR T-cell Activity
Robbie G. Majzner et al.
CANCER DISCOVERY (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
Wei Wu et al.
CELL (2020)
Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function
Frederike A. Hartl et al.
NATURE IMMUNOLOGY (2020)
Inefficient CAR-proximal signaling blunts antigen sensitivity
Venugopal Gudipati et al.
NATURE IMMUNOLOGY (2020)
Human CD8+ T Cells Exhibit a Shared Antigen Threshold for Different Effector Responses
Enas Abu-Shah et al.
JOURNAL OF IMMUNOLOGY (2020)
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Philippos Demetriou et al.
NATURE IMMUNOLOGY (2020)
CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering
Robbie G. Majzner et al.
BLOOD (2020)
B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response
Patrick A. Baeuerle et al.
NATURE COMMUNICATIONS (2019)
Single variable domains from the T cell receptor β chain function as mono- and bifunctional CARs and TCRs
Julyun Oh et al.
SCIENTIFIC REPORTS (2019)
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn et al.
NATURE (2019)
Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
Daniel T. Harris et al.
JOURNAL OF IMMUNOLOGY (2018)
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry et al.
NATURE MEDICINE (2018)
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Jennifer N. Brudno et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses
Eddie C. Y. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density
John R. James
SCIENCE SIGNALING (2018)
Chimeric antigen receptors that trigger phagocytosis
Meghan A. Morrissey et al.
ELIFE (2018)
Tuning ITAM multiplicity on T cell receptors can control potency and selectivity to ligand density
John R. James
SCIENCE SIGNALING (2018)
Molecular mechanisms of T cell sensitivity to antigen
Jesus A. Siller-Farfan et al.
IMMUNOLOGICAL REVIEWS (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
CD8+ T-cell specificity is compromised at a defined MFICl/CD8 affinity threshold
Tamsin Dockree et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization
Esther Drent et al.
MOLECULAR THERAPY (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse
F. R. Abdul Razak et al.
GENES AND IMMUNITY (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Architecture of a minimal signaling pathway explains the T-cell response to a 1 million-fold variation in antigen affinity and dose
Melissa Lever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
Marcela V. Maus et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
Zeguo Zhao et al.
CANCER CELL (2015)
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
Xiaojun Liu et al.
CANCER RESEARCH (2015)
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
Hillary G. Caruso et al.
CANCER RESEARCH (2015)
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28-CD8+ T Cells
Judith Leitner et al.
JOURNAL OF IMMUNOLOGY (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
TCR ITAM multiplicity is required for the generation of follicular helper T-cells
SuJin Hwang et al.
NATURE COMMUNICATIONS (2015)
A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells
Jun Huang et al.
IMMUNITY (2013)
T cell receptor signalling networks: branched, diversified and bounded
Rebecca J. Brownlie et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cells
E. J. Cheadle et al.
GENE THERAPY (2012)
Non-catalytic tyrosine-phosphorylated receptors
Omer Dushek et al.
IMMUNOLOGICAL REVIEWS (2012)
Interplay between T Cell Receptor Binding Kinetics and the Level of Cognate Peptide Presented by Major Histocompatibility Complexes Governs CD8+ T Cell Responsiveness
Melita Irving et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen
Sharyn Thomas et al.
BLOOD (2011)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Antigen Potency and Maximal Efficacy Reveal a Mechanism of Efficient T Cell Activation
Omer Dushek et al.
SCIENCE SIGNALING (2011)
Mechanisms for T cell receptor triggering
P. Anton van der Merwe et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time
Milos Aleksic et al.
IMMUNITY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Rational development of high-affinity T-cell receptor-like antibodies
Guillaume Stewart-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity
Jeff Holst et al.
NATURE IMMUNOLOGY (2008)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities
SL Hutchinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation
PD Holler et al.
IMMUNITY (2003)
Direct observation of ligand recognition by T cells
DJ Irvine et al.
NATURE (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor ζ chain
MA Purbhoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
ITAM multiplicity and thymocyte selection: How low can you go?
PE Love et al.
IMMUNITY (2000)
分享论文
